Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

HuiyiHuiying Raises Funds from Intel for Medical Imaging AI

publication date: Nov 7, 2018

HuiyiHuiying (HY), a Beijing AI medical imaging company, has closed a funding round that was led by Intel Capital and included Beijing Singularity Power Investment Fund. The size of the funding was not disclosed. Previously, HY had established a joint AI lab with Intel. In September, HY and Intel announced a collaboration to develop an AI full-cycle breast health management cloud platform, which will support breast cancer screening and diagnosis. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
ChinaBio Partnering Forum 2019
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events